We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




“Social Media Network” for the Chronically Ill

By HospiMedica International staff writers
Posted on 26 Mar 2013
A mobile and web platform for patients with chronic conditions offers data consolidation among a variety of patient monitoring devices. More...


The Wellaho Personalized Outpatient Management System assists the collection of physiological data, such as blood pressure, blood sugar levels, and patient vital signs, from outpatients being treated for cancer and other chronic diseases. Physician-directed, web-based, and mobile platforms allow providers to supervise and monitor patients between office visits in a secure, Health Insurance Portability and Accountability Act (HIPAA) compliant environment, while enabling patients to access their medical information, monitor their condition, stream relevant educational materials, and connect securely to their doctors and healthcare team.

The system maintains patient data on a secure data storage server that can be accessed by the patient, the patient’s doctors, and certain other health care providers. It also enables patients to provide daily personal updates about their own health status to describe their relative fatigue, pain level, mood, and how well they are eating. Patients also access medical information about their own health, monitor their condition, get relevant educational information, and to communicate with their doctors and healthcare team. The Wellaho system is a product of Sanitas (San Diego, CA, USA), and has been approved by the US food and drug Administration (FDA).

“Given the tsunami of new apps and technologies that hit the market each year, both patients and providers need the highest validation for the products and services they use,” said Naser Partovi, CEO of Sanitas. “Wellaho offers one more reason for providers and patients to trust that we can provide a safe, secure, and effective solution for managing their care.”

Related Links:

Sanitas



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Pocket Fetal Doppler
CONTEC10C/CL
New
Sling
GoComfort
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.